Your browser doesn't support javascript.
loading
microRNA-26a Directly Targeting MMP14 and MMP16 Inhibits the Cancer Cell Proliferation, Migration and Invasion in Cutaneous Squamous Cell Carcinoma.
Zheng, Wang; Li, Zong-Yu; Zhao, De-Lai; Li, Xing-Long; Liu, Rui.
Afiliación
  • Zheng W; Department of Burns, The Fifth Hospital of Harbin, Harbin 150040, People's Republic of China.
  • Li ZY; Department of Burns, The Fifth Hospital of Harbin, Harbin 150040, People's Republic of China.
  • Zhao DL; Department of Burns, The Fifth Hospital of Harbin, Harbin 150040, People's Republic of China.
  • Li XL; Department of Orthopedic Surgery, The Fifth Hospital of Harbin, Harbin 150040, People's Republic of China.
  • Liu R; Department of Burns, The Fifth Hospital of Harbin, Harbin 150040, People's Republic of China.
Cancer Manag Res ; 12: 7087-7095, 2020.
Article en En | MEDLINE | ID: mdl-32848463
PURPOSE: To investigate the specific effect and underlying mechanism of microRNA-26a-5p (miR-26a) in cutaneous squamous cell carcinoma (CSCC). METHODS: miR-26a and MMP14/16 mRNA expression were detected by qRT-PCR analysis. Functional experiments were used to detect the role of miR-26a on CSCC progression. Western blot was used for protein detection. Luciferase assay was used to detect miR-26a directly targeting MMP14 and MMP16. Xenograft nude mice model was used to determine the effect of miR-26a on tumorigenesis. RESULTS: miR-26a was decreased in CSCC tissues and cells. Forced miR-26a suppressed the progression of SCL-1 and A431 cells. Furthermore, miR-26a directly targeted MMP14 and MMP16 to inhibit their expression. Forced expression of MMP14 and MMP16 removed the miR-26a's inhibitory effect on CSCC development. The in vivo tumor growth assay showed that miR-26a suppressed CSCC tumorigenesis by targeting MMP14 and MMP16. CONCLUSION: Our study suggested miR-26a inhibits cancer cell proliferation, migration and invasion in CSCC by targeting MMP14 and MMP16.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancer Manag Res Año: 2020 Tipo del documento: Article Pais de publicación: Nueva Zelanda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancer Manag Res Año: 2020 Tipo del documento: Article Pais de publicación: Nueva Zelanda